Q&A: Israel-Gaza conflict halts vaccine rollout
SciDev.net
; 2021.
Article
in English
| ProQuest Central | ID: covidwho-1998385
ABSTRACT
According to the United Nations High Commissioner for Refugees (UNHCR), conflicts in the region have left around 17 million refugees. How could the WHO approve the vaccine when clinical trials didn’t target a significant number of people and when, according to a document published by Reuters, some WHO experts were sceptical? There have also been some trials on people above 60 years old but on a smaller number, so it is hard to measure the efficacy for this group. [...]WHO recommends that countries using the vaccine should monitor its safety and efficacy.
Medical Sciences; Clinical trials; COVID-19 vaccines; Refugees; Vaccines; Genomes; Medical supplies; Immunization; Pandemics; Effectiveness; Coronaviruses; Afghanistan; Gaza Strip; Egypt; Libya; Bahrain; Syria; Oman; Middle East; Saudi Arabia; Lebanon; Pakistan; Iran; Morocco; Qatar; Israel; Iraq; Kuwait; Tunisia; Yemen
Search on Google
Collection:
Databases of international organizations
Database:
ProQuest Central
Topics:
Vaccines
Language:
English
Journal:
SciDev.net
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS